We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $14.1B
1-Year Est. Return 30.11%
This Fund
S&P 500
This Quarter Est. Return
+3.81%
1 Year Est. Return
+30.11%
3 Year Est. Return
+110.39%
5 Year Est. Return
+152.15%
10 Year Est. Return
+370.53%
AUM
$13.3B
AUM Growth
+$700M
Cap. Flow
+$449M
Cap. Flow %
3.37%
Top 10 Hldgs %
41.95%
Holding
1,618
New
92
Increased
926
Reduced
540
Closed
48

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$25.8M
2
META icon
Meta Platforms (Facebook)
META
+$20.6M
3
MSFT icon
Microsoft
MSFT
+$18.6M
4
NVDA icon
NVIDIA
NVDA
+$15.3M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$12.9M

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$6.88M
2
MPC icon
Marathon Petroleum
MPC
+$4.71M
3
K
Kellanova
K
+$3.29M
4
J icon
Jacobs Solutions
J
+$2.43M
5
SNA icon
Snap-on
SNA
+$2.28M

Sector Composition

Rank Sector Weight
1 Technology 38.09%
2 Financials 11.48%
3 Consumer Discretionary 11.15%
4 Communication Services 11.06%
5 Healthcare 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLND icon
1526
Blend Labs
BLND
$409M
$47.9K ﹤0.01%
15,754
-535
-3% -$1.71K
BTBT icon
1527
Bit Digital
BTBT
$484M
$47.2K ﹤0.01%
24,970
+134
+0.5% +$387
FIP icon
1528
FTAI Infrastructure
FIP
$500M
$47K ﹤0.01%
+10,193
New +$50.2K
GOSS icon
1529
Gossamer Bio
GOSS
$66.5M
$46.2K ﹤0.01%
14,897
+75
+0.5% +$214
UWMC icon
1530
UWM Holdings
UWMC
$621M
$46K ﹤0.01%
+10,506
New +$56.5K
IBRX icon
1531
ImmunityBio
IBRX
$7.44B
$45.9K ﹤0.01%
23,168
+5,270
+29% +$11.9K
IHRT icon
1532
iHeartMedia
IHRT
$535M
$45.5K ﹤0.01%
+10,939
New +$40.9K
MVST icon
1533
Microvast
MVST
$267M
$44.1K ﹤0.01%
15,734
+166
+1% +$694
IRWD icon
1534
Ironwood Pharmaceuticals
IRWD
$611M
$41.9K ﹤0.01%
12,419
+80
+0.6% +$208
TALK icon
1535
Talkspace
TALK
$873M
$40.9K ﹤0.01%
11,269
OPK icon
1536
Opko Health
OPK
$921M
$40.8K ﹤0.01%
32,361
+191
+0.6% +$266
TEF
1537
DELISTED
Telefonica
TEF
$40.5K ﹤0.01%
+10,008
New +$45.1K
PACB icon
1538
Pacific Biosciences
PACB
$422M
$40.1K ﹤0.01%
21,467
SABR icon
1539
Sabre
SABR
$656M
$39.7K ﹤0.01%
29,226
+801
+3% +$1.38K
BDN
1540
Brandywine Realty Trust
BDN
$551M
$39.6K ﹤0.01%
13,556
+136
+1% +$463
RR icon
1541
Richtech Robotics
RR
$347M
$38.3K ﹤0.01%
+11,864
New +$52.5K
REAX icon
1542
Real Brokerage
REAX
$368M
$37.7K ﹤0.01%
+10,319
New +$39.9K
ABSI icon
1543
Absci
ABSI
$1.28B
$36.7K ﹤0.01%
+10,525
New +$38.4K
RZLV
1544
Rezolve AI
RZLV
$893M
$36K ﹤0.01%
14,019
+2,514
+22% +$9.48K
NXDR
1545
Nextdoor Holdings
NXDR
$835M
$35.7K ﹤0.01%
17,005
+461
+3% +$904
EU
1546
enCore Energy
EU
$221M
$35.6K ﹤0.01%
14,359
GEVO icon
1547
Gevo
GEVO
$397M
$35.6K ﹤0.01%
17,796
-162
-0.9% -$357
OPTU
1548
Optimum Communications Inc
OPTU
$316M
$33.7K ﹤0.01%
20,436
+60
+0.3% +$122
KOS icon
1549
Kosmos Energy
KOS
$1.56B
$33.3K ﹤0.01%
36,681
-463
-1% -$610
AKBA icon
1550
Akebia Therapeutics
AKBA
$327M
$32.1K ﹤0.01%
19,945
+399
+2% +$835

Similar funds

Xponance's Q4 2025 Portfolio in Review

As of Q4 2025, Xponance held 1,618 positions worth $13.3B, up 5.5% from $12.6B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Xponance deployed $449M of net new capital in Q4 2025, opening 92 new positions and adding to 926 existing holdings. Its largest new stake was Solstice Advanced Materials: 63,792 shares worth $3.1M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 39% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was DuPont de Nemours, an estimated $6.88M trimmed.

  • Xponance's largest Q4 2025 buy was Solstice Advanced Materials: 63,792 shares worth $3.1M.
  • Xponance added most to Amazon in Q4 2025, an estimated $25.8M increase.
  • Xponance's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $6.88M.
  • Xponance fully exited Kellanova in Q4 2025, selling an estimated $3.29M.
  • Xponance's ten largest holdings make up 42% of its $13.3B portfolio in Q4 2025.
  • Xponance opened 92 new positions and closed 48 in Q4 2025.
  • Xponance's portfolio value rose 5.5% quarter-over-quarter to $13.3B.

Based on Xponance's 13F filing for Q4 2025, filed 12 Feb 2026.